HERON THERAPEUTICS, INC. /DE/ Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
HERON THERAPEUTICS, INC. /DE/ (HRTX) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $385.00 thousand as of 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2025-02-27
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $385.00K.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $137.00K.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $0.00.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $1.70M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value as first filed |
|---|---|---|
| 2024-12-31 | $385.00K 10-K · filed 2025-02-27 | |
| 2023-12-31 | $137.00K 10-K · filed 2025-02-27 | |
| 2022-12-31 | $0.00 10-K · filed 2025-02-27 | |
| 2021-12-31 | $1.70M 10-K · filed 2023-03-29 | |
| 2020-12-31 | $69.10M 10-K · filed 2022-02-28 | $69.10K 10-K · filed 2021-02-24 |
| 2019-12-31 | $56.30K 10-K · filed 2021-02-24 | |
| 2018-12-31 | $75.70K 10-K · filed 2020-03-02 | $75.70M 10-K · filed 2019-02-22 |
| 2017-12-31 | $35.60M 10-K · filed 2019-02-22 | |
| 2016-12-31 | $16.90M 10-K · filed 2018-02-27 | |
| 2015-12-31 | $46.60M 10-K · filed 2017-02-23 | $46.60M 10-K · filed 2016-02-19 |
| 2014-12-31 | $14.65M 10-K · filed 2016-02-19 | |
| 2013-12-31 | $4.94M 10-K · filed 2015-03-13 | $10.70M 10-K · filed 2014-03-07 |
| 2012-12-31 | $14.56M 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |